Clinical Trial

Safety and Pharmacokinetics Study of Multiple Ascending Doses of VV913 Capsules

Name: Safety and Pharmacokinetics Study of Multiple Ascending Doses of VV913 Capsules — clinical trial record (NCT07507838)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Early Phase 1

View on ClinicalTrials.gov →

Summary

This study is a single-center, randomized, double-blind, placebo-controlled, dose-escalation trial to assess the safety, tolerability, pharmacokinetics （PK） of multiple doses of VV913 in Chinese healthy adult participants.

Protocol Amendment History 1 change

critical Recruitment opened 2026-07-15

Trial Details

NCT Number	NCT07507838
Lead Sponsor	Vigonvita Life Sciences
Conditions	Healthy Volunteers
Enrollment	24 participants
Start Date	2026-04-13
Primary Completion	2026-12-31 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-07-14